Yiqiao Hu Selected Research

perfluorotributylamine (FC 43)

11/2019	Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy.
11/2018	Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen-Sensitive Antitumor Drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiqiao Hu Research Topics

Disease

70	Neoplasms (Cancer) 06/2022 - 10/2007
13	Hypoxia (Hypoxemia) 06/2022 - 02/2012
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 03/2014
3	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2018
2	Wounds and Injuries (Trauma) 12/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 05/2017 - 02/2012
2	Phototoxic Dermatitis (Phototoxicity) 02/2017 - 02/2015
1	Inflammation (Inflammations) 12/2022
1	Bites and Stings (Sting) 10/2021
1	Triple Negative Breast Neoplasms 12/2018
1	Hyperthermia 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 12/2016

Drug/Important Bio-Agent (IBA)

12	Oxygen (Dioxygen)IBA 06/2022 - 11/2015
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022 - 02/2015
9	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 02/2015
9	Pharmaceutical PreparationsIBA 01/2020 - 09/2009
8	Coloring Agents (Dyes)IBA 07/2018 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
5	AlbuminsIBA 11/2019 - 05/2013
4	HydrogelsIBA 12/2022 - 10/2014
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2019 - 01/2018
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2019 - 12/2012
4	Liposomes (Liposome)IBA 11/2019 - 02/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2018 - 02/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 01/2018
3	PolymersIBA 01/2021 - 01/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 01/2013
3	FluorocarbonsIBA 11/2019 - 01/2017
3	Antineoplastic Agents (Antineoplastics)IBA 11/2018 - 05/2013
3	MicellesIBA 02/2017 - 05/2015
3	Human Serum Albumin FDA LinkGeneric 01/2017 - 07/2011
2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 10/2021
2	GadoliniumIBA 04/2022 - 01/2021
2	AntigensIBA 04/2022 - 01/2022
2	perfluorotributylamine (FC 43)IBA 11/2019 - 11/2018
2	Small Interfering RNA (siRNA)IBA 05/2017 - 01/2013
2	Hyaluronic Acid (Hyaluronan)IBA 05/2017 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2017 - 10/2016
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017 - 02/2015
2	Transferrin (beta 2 Transferrin)IBA 01/2016 - 07/2012
2	Singlet OxygenIBA 11/2015 - 03/2015
2	phytochlorinIBA 07/2015 - 02/2015
2	MicroRNAs (MicroRNA)IBA 01/2013 - 10/2011
1	HydrogenIBA 12/2022
1	AntioxidantsIBA 12/2022
1	Superoxides (Superoxide)IBA 06/2022
1	paragonIBA 04/2022
1	physcioneIBA 04/2022
1	NucleotidesIBA 04/2022
1	hydroxide ionIBA 04/2022
1	NADP (NADPH)IBA 04/2022
1	OvalbuminIBA 01/2022
1	SolutionsIBA 01/2022
1	ManganeseIBA 10/2021
1	Divalent CationsIBA 10/2021
1	AlginatesIBA 10/2021
1	A-Form DNA (A-DNA)IBA 06/2021
1	CopperIBA 01/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	CatalaseIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 12/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2020
1	Drug CarriersIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2019
1	ProdrugsIBA 01/2019
1	Albumin-Bound Paclitaxel FDA Link 12/2018
1	CytokinesIBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018
1	AcriflavineIBA 01/2018
1	manganese dioxideIBA 01/2018
1	calcium phosphateIBA 05/2017
1	coumarinIBA 02/2017
1	EstersIBA 02/2017
1	PEG-PAMAMIBA 01/2017
1	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2017
1	Sincalide FDA Link 01/2017

Therapy/Procedure

27	Therapeutics 01/2022 - 03/2009
13	Drug Therapy (Chemotherapy) 12/2020 - 10/2007
11	Radiotherapy 06/2022 - 01/2016
11	Photochemotherapy (Photodynamic Therapy) 06/2022 - 01/2013
7	Lasers (Laser) 01/2017 - 02/2015
5	Immunotherapy 04/2022 - 11/2019
5	Intravenous Injections 02/2017 - 05/2015
3	Intravesical Administration 01/2017 - 10/2014
3	Photothermal Therapy 03/2016 - 03/2015
2	Radioimmunotherapy 01/2021 - 01/2021
2	Phototherapy (Light Therapy) 01/2017 - 01/2016
2	Precision Medicine 01/2017 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Chemoradiotherapy 11/2017
1	Oral Administration 05/2017
1	Castration 01/2017
1	Transurethral Resection of Bladder 01/2017
1	Cystectomy 01/2017